_________
false
אנלייבקס תרפיוטיקס בע"מ
2
379
ENLIVEX THERAPEUTICS LTD
Corporation no:
514716489
12568
Israel Securities Authority
Tel Aviv Stock Exchange
C001
(
Public
)
Reported via MAGNA:
23/01/2020
www.isa.gov.il
www.tase.co.il
Reference:
2020-02-009735
Time of broadcast:
23:34
23:30:42
Report of Periodic or Interim Report
Regulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
20-F/A
20F_isa.pdf
Link to filing on foreign stock exchange (optional):
_________
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
-1
Date of revision of form structure:
31/12/2019
Address:
Einstein
14
,
NES-ZIONA
7403618
,
ISRAEL
Tel:
02-6708072
,
Fax:
02-6708070
E-mail address:
shachar@enlivexpharm.com
Company site:
www.enlivex.com
Previous names of reporting entity:
Name of the Signatory:
SHLOSBERGER SHACHAR
Position of Signatory in the reporting corporation:
Chief Financial Officer
Name of Employer Company:
Enlivex thetraputics R&D
Address:
Nachal Dan
19
,
Qiryat Uno
61580
Telephone:
054-4617610
Facsimile:
-
E-mail:
shachar@ramdor.co.il
2
ISRAEL